#USA #Hackensack #MAX Surgical #Jason Auerbach #Jeffrey DeBellis

Strategic Leadership Changes at MAX Surgical

MAX Surgical Specialty Management, a prominent player in the oral and maxillofacial surgery (OMS) sector in the Northeast, announced today significant changes in its leadership team. Dr. Jason M. Auerbach, the founder of the organization in 2022, has been named Chief Executive Officer (CEO), while Jeffrey DeBellis has been elevated to the role of President and Chief Operating Officer (COO). These shifts are set against a backdrop of ambitious plans for growth, aimed at streamlining operations and reinforcing the organization’s commitment to its surgical partners.

With Dr. Auerbach at the helm as CEO, the organization is poised to deepen its focus on the clinical and cultural needs of its partners.
"MAX was founded on the principle that surgeons require a support structure that comprehensively understands their specialty, as we live this reality every day," shared Dr. Auerbach. This philosophy will guide the company as it supports its expanding network of over 50 surgeons across more than 40 locations in New Jersey, New York, Pennsylvania, Connecticut, and Vermont.

DeBellis's promotion to President and COO brings him into a critical role where he will manage day-to-day operations. He emphasizes that the restructuring allows for more targeted leadership: "Jason’s clinical background remains the bedrock of MAX’s operations. Now, with our new structure, my priority is to enhance the performance of every practice that joins MAX, not merely through contractual agreements but by ensuring tangible support from day one."

As the pressure to deliver optimal patient care increases, MAX's aim is to empower its partner practices with a comprehensive range of administrative support. This includes assistance in operations, marketing, human resources, finance, and compliance, among other essential areas. Jos Couper retains his position as Chief Financial Officer, likely to maintain the financial health and strategic investments vital to the company’s success.

In the eyes of Jeff Ward from MedEquity Capital, the organization's principal investor, the leadership capabilities of Auerbach and his team are pivotal to the ongoing expansion of MAX. "Our belief in Jason’s vision has driven our ongoing investment. We are confident in his leadership, and this restructuring aligns with our ambition to enhance MAX's standing as a leader in the oral and maxillofacial surgery domain."

MAX's commitment to maintain the clinical autonomy of its practices while providing substantial operational support illustrates a balanced approach to modern healthcare delivery. The organization firmly believes that the best patient outcomes are achieved by empowering surgeons rather than managing them remotely. The transition into this next phase of growth accentuates MAX's ambition to redefine the landscape of oral and maxillofacial surgery through strong leadership and strategic partnerships.

About MAX Surgical Specialty Management

Founded in 2022, MAX Surgical Specialty Management is committed to revolutionizing the future of oral and maxillofacial surgery. As a management services organization led by surgeons, MAX focuses on enabling clinical leaders to succeed by providing robust operational support, advanced technologies, and a network of elite professionals. This approach preserves the unique identities of individual practices while enhancing patient care, promoting professional growth, and ensuring sustainable success for surgeons across the region.

With backing from MedEquity Capital, RF Investment Partners, and Kian Capital, MAX is strategically positioned for growth within the Northeast and beyond. For further information, please visit www.max-ssm.com.